Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-16

Clinical Trial Update: A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan [Phase 3]

View source ↗

Summary

Phase 3 trial update for duloxetine in chronic osteoarthritis knee pain in Japan; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED | Results posted: 2017-01-16